The Second Affiliated Hospital, School of Medicine, Zhejiang University
The Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of IBI351, Cetuximab β Combined With FOLFIRI as First-line /IBI351, Cetuximab β as Second-line in the Treatment of KRAS G12C-mutated Metastatic Colorectal Cancer | Colorectal Cancer Metastatic; KRAS G12C Mutation | Enrolling by invitation | Phase 2 | 2026-05-11 | NCT06959589 |